News for Smith & Nephew plc (SNN)

Smith+Nephew (LSE:SN, :SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair

**media[562233]**

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair…

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Associa…

Smith+Nephew (LSE:SN, :SNN), the global medical technology company, today announces its pioneering efforts to develop technology in the field of Spatial Surgery

Insights from the Fourth Quarter of 2024 Causeway International Value (Trades, Portfolio) recently submitted its N-PORT filing for the fourth quarter of 2024,

The following slide deck was published by Smith & Nephew plc in conjunction with their 2024 Q4 earnings call.

We recently published a list of 10 Safest Dividend Stocks in the UK.

In recent years, investors have increasingly shifted away from UK equities, favoring global stocks, particularly high-growth sectors like US technology.

**media[530997]**

Smith & Nephew's stock underperformance due to market share losses & pricing pressures in China.

We recently compiled a list of the U.K.

**media[496980]**

US, UK equities upgraded at UBS, Europe downgraded

The UK Home Healthcare Market Size sector reached a market value of USD 1.50 Billion in 2022. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 7.1% from 2022 to…

Biggest stock movers Monday: Crypto stocks and TSLA. McKesson, Oracle among finalists to acquire Veradigm: report. Smith & Nephew investors may push for breakup - Mail on Sunday.

Read why Smith & Nephew stock faces short-term challenges but remains a strong long-term investment opportunity with a solid growth plan and undervalued metrics.

Shareholders of Smith & Nephew (SNN) may push for a breakup if CEO Deepak Nath fails to improve performance, particularly in the orthopaedics division.

Robust Use of Cold Plasma in Bioengineering, Medicinal, and Food Processing Sectors Bolstering Market Sales...